Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings.

Mladsi, Deirdre M

Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. [electronic resource] - Current medical research and opinion Dec 2004 - 1883-93 p. digital

Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

0300-7995

10.1185/030079904X11510 doi


Adult
Antipsychotic Agents--economics
Benzodiazepines--economics
Costs and Cost Analysis
Dibenzothiazepines--economics
Drug Costs--statistics & numerical data
Female
Humans
Inpatients
Male
Mental Health Services--statistics & numerical data
Middle Aged
Olanzapine
Quetiapine Fumarate
Retrospective Studies
Risperidone--economics
Schizophrenia--drug therapy